HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.

BACKGROUND AND AIMS:Harm reduction strategies have been shown to decrease the incidence of human immunodeficiency virus (HIV) infection in people who inject drugs (PWID), but the results have been inconsistent when it comes to prevention of hepatitis C virus (HCV) infection. We aimed to examine the...

Full description

Bibliographic Details

Published in:	PLoS ONE
Main Authors:	Jorge Valencia La Rosa, Pablo Ryan, Alejandro Alvaro-Meca, Jesús Troya, Guillermo Cuevas, Jorge Gutiérrez, Santiago Moreno
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Online Access:	http://europepmc.org/articles/PMC6169909?pdf=render